CRC
California Resources Corporation
Set alert
55.46 USD +0.79 +1.45%
54.72 Day range 55.69
43.55 52-week range 70.13
- YTD
- +24.04%
- 1 year
- +18.30%
- Open
- 55.11
- Prev close
- 54.67
- Mkt cap
- 4.93B
- Vol
- 860.23K
- Avg vol
- 850.15K
- EPS
- -1.29
- P/E
- 0.00
- Div yield
- 2.96%
More statistics
- Low
- 54.72
- High
- 55.69
- Forward P/E
- 15.87
- Beta
- 1.02
- Short ratio
- 5.16
- Inst. own
- 105.72%
- Dividend
- 1.62
- Ex-div date
- Sep 3, 2026
- Earnings
- Nov 2, 2026
- 50-d avg
- 53.57
- 200-d avg
- 57.08
- 1y target
- 75.33
Key statistics
- Market cap
- 4.93B
- Enterprise value
- 6.15B
- Trailing P/E
- 0.00
- Forward P/E
- 15.87
- PEG ratio
- 0.53
- Price / sales
- 1.32
- Price / book
- 1.45
- EPS (TTM)
- -1.29
- Beta
- 1.02
- Dividend yield
- 2.96%
- Payout ratio
- 37.77%
- Profit margin
- -3.24%
- Revenue (TTM)
- 3.74B
- Revenue growth
- 33.00%
- Free cash flow
- 299.50M
- Total cash
- 56.00M
- Total debt
- 1.35B
- Return on equity
- -3.55%
- Shares outstanding
- 88.82M
- Short % of float
- 7.52%
- 50-day average
- 53.57
- 200-day average
- 57.08
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 75.33 +35.8% upside
Now 55.46
- Target (low)
- 59.00
- Target (mean)
- 75.33
- Target (high)
- 91.00
Ratings (0m) 13 12 buy · 1 hold · 0 sell
- Strong buy3
- Buy9
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 2, 2026
Expected Nov 2, 2026. Consensus EPS estimate 0.96646.
Financials — quick view
CRC Revenue — quarterly 1.30B
CRC Net income — quarterly 514.00M
CRC EPS — quarterly 5.79
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 2, 2026 | Sep 30, 2026 | 1.00 | — | — | — |
| Aug 10, 2026 | Jun 30, 2026 | 1.36 | 0.99 | -0.37 | -27.21% |
| May 5, 2026 | Mar 31, 2026 | 0.83 | 0.88 | +0.05 | +6.02% |
| Mar 2, 2026 | Dec 31, 2025 | 0.49 | 0.47 | -0.02 | -4.08% |
| Nov 4, 2025 | Sep 30, 2025 | 1.31 | 1.46 | +0.15 | +11.45% |
| Aug 5, 2025 | Jun 30, 2025 | 0.91 | 1.10 | +0.19 | +20.88% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | UBS | main | Buy | Buy |
| Sep 18, 2026 | Stephens & Co. | main | Overweight | Overweight |
| Sep 17, 2026 | Roth Capital | main | Buy | Buy |
| Sep 14, 2026 | UBS | main | Buy | Buy |
| Sep 14, 2026 | RBC Capital | reit | Outperform | Outperform |
| Sep 3, 2026 | Seaport Global | init | — | Neutral |
About California Resources Corporation
California Resources Corporation operates as an independent energy and carbon management company in the United States. The company operates in two segments, Oil and Natural Gas, and Carbon Management. It explores, develops, and produces crude oil, oil condensate, natural gas liquids and natural gas to california refineries, marketers, and other purchasers. The company also provides Carbon TerraVault which builds, installs, operates, and maintains CO2 capture equipment, transportation assets, and storage facilities. In addition, it owns and operates power generation facilities, as well as smaller gas-fired power plants used to generate power for oil and natural gas operations. The company was incorporated in 2014 and is based in Long Beach, California.
- Sector
- Energy
- Industry
- Oil & Gas E&P
- Country
- United States
- Website
- crc.com
News
- Analysts Estimate California Resources Corporation (CRC) to Report a Decline in Earnings: What to Look Out for
- Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
- Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
- Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
- Ziihera® (zanidatamab-hrii) Combinations Demonstrate Sustained Survival at Three Years in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma at ESMO 2026
- Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium
- Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option
- /C O R R E C T I O N - AbbVie/
- Incyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
- ESMO 2026 Presentations Deepen the Evidence Base for Natera's Oncology Portfolio and Leadership in Ultrasensitive MRD Technology
Your note
Sign in to keep a note on CRC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BYS JAY A | Officer | Sale | Oct 11, 2026 | 123,703 |
| CANADA PENSION PLAN INVESTMENT BOARD | Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 11, 2026 | 0 |
| CEPAK TIFFANY THOM | Director | Stock Award(Grant) | Apr 29, 2026 | 86,325 |
| CRESPY CLIO C | Chief Financial Officer | Stock Award(Grant) | Mar 1, 2026 | 98,501 |
| GOULD CHRISTOPHER D | Officer | Sale | Mar 10, 2026 | 131,537 |
| HAYAT OMAR | Chief Operating Officer | Stock Award(Grant) | Jun 17, 2026 | 83,492 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 13.49% | 11,977,441 | 664.75M | Jun 29, 2026 |
| Canada Pension Plan Investment Board | 7.89% | 7,006,895 | 388.88M | Jun 29, 2026 |
| Gimbel Daniel Scott | 7.03% | 6,240,865 | 346.37M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.94% | 5,273,055 | 292.65M | Jun 29, 2026 |
| Sourcerock Group, LLC | 5.51% | 4,890,388 | 271.42M | Jun 29, 2026 |
| State Street Corporation | 4.84% | 4,303,304 | 238.83M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.48% | 4,866,615 | 270.10M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.02% | 2,682,877 | 148.90M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.25% | 1,996,548 | 110.81M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.18% | 1,935,419 | 107.42M | Jun 29, 2026 |
| AIM Sector Funds (Invesco Sector Funds)-Invesco Small Cap Value Fund | 1.87% | 1,665,345 | 92.43M | Jul 30, 2026 |
| SPDR SERIES TRT-State Street SPDR S&P Oil & Gas Exploration & Producti | 1.59% | 1,415,288 | 78.55M | Sep 29, 2026 |